ABG
CVAC

Ally Bridge Group’s CureVac CVAC Stock Holding History

Ally Bridge Group’s Portfolio CVAC Stock Details CVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-110,000
Closed -$10.1M – 31
2021
Q1 		$10.1M Buy
+110,000
New +$10.7M 1.93% 17

Other funds holding CVAC

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ally Bridge Group's CVAC Position: Q2 2021 in Review

Ally Bridge Group sold out of CureVac (CVAC) in Q2 2021, closing a stake of 110,000 shares — an estimated $10.1M sold.

Ally Bridge Group first reported a position in CVAC in Q1 2021 and held it in 1 quarter. The position peaked at $10.1M in Q1 2021. 109 funds tracked by Wall St. Rank hold CVAC as of Q2 2021.

  • Ally Bridge Group reported no remaining CureVac position as of Q2 2021 after selling out during the quarter.
  • Ally Bridge Group sold 110,000 CureVac shares in Q2 2021, an estimated $10.1M.
  • Ally Bridge Group first reported a position in CureVac in Q1 2021 and held it in 1 quarter.
  • Ally Bridge Group's CureVac position peaked at $10.1M in Q1 2021.
  • 109 funds tracked by Wall St. Rank held CureVac as of Q2 2021.

Based on Ally Bridge Group's 13F filing for Q2 2021, filed 16 Aug 2021.